Navigation Links
Contact Lens Shift Can Compromise Vision of People with Astigmatism with the Blink of an Eye
Date:12/5/2007

Clinical study compares rotational stability of two differently designed toric soft contact lenses over a range of every day viewing conditions

JACKSONVILLE, Fla., Dec. 5 /PRNewswire/ -- For contact lens wearers who wonder why their vision may sometimes fluctuate during the day, the answer may lie in the design of their contact lens, a new clinical study demonstrates. The findings, say researchers, may be of particular interest to the more than 11 million wearers of soft toric contact lenses for the treatment of astigmatism, a common vision condition in which surfaces of the eye, including the cornea, have an oval shape. The findings appear in the current issue of Optometry and Vision Science, the peer-reviewed journal of the American Academy of Optometry.

(Photo: http://www.newscom.com/cgi-bin/prnh/20071205/CLW016 )

According to the study, which used a novel, infrared, video-based technique to evaluate the clinical performance of two of the most frequently prescribed toric soft contact lenses in the United States, lenses utilizing an Accelerated Stabilization Design were superior when compared to lenses using a Prism Ballast Design in two of four tasks designed to mimic real-world viewing conditions involving quick, simultaneous movements of both eyes in the same direction.

"During wide angle eye movements, tasks such as scanning a newspaper for information, gazing to the extreme side for changing lanes while driving or parking/backing up, or trying to view a flag on a putting green while teeing off in golf, a rotated contact lens can greatly compromise vision, resulting in blur and a temporary loss of visual clarity," says study co-author George A. Zikos, O.D., M.S., Manhattan Vision Associates/Institute Vision Research. "The rotational position and stability of a contact lens on the eyes during movement are critical in ensuring consistent vision whi
'/>"/>

SOURCE Vistakon
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities
2. Service-to-Sales Transformation at Contact Centers Hinges on Soft Skills
3. Presentation at Bio Contact Quebec 2007
4. ILC Dover Launches Revolutionary ArmorFlex (R) Pharmaceutical Product Contact Film
5. ACUVUE(R) 2 COLOURS(R) Brand Contact Lenses Launches Virtual Eye Makeover Tool
6. Worlds First Non-Contact Thermometer for Children Now Available at Walgreens Nationwide
7. ECO2 Plastics to File for FDA Approval for Food-Contact Applications
8. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
9. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
10. Shape Shifting on Veterans Day
11. WHO Study: Night Shift Work May Cause Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Benton Communications announces a highly...em for retailers struggling to make an economic re...r 26, 2009 -- Flu fears is the type of challenge t...cy room, according to Dr. David Benton, business g...ness growth system – The Rfactor Intensive ...
(Date:11/25/2009)...ndCALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc....I)coilsandsoftwareandCalgaryScientificInc.,aleadin...ucedawebversionofAegis(TM)Breast4DAdvancedVisualiz...irsttrulyzero-footprintWebclientbasedmedicalimagin...)platformallowsforzero-footprintaccess-requiringno...
(Date:11/25/2009)...ISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityManag...pare the Air Alert forThursday,November...anyothersolidfuel,bothindoorsandoutdoors. ,, "C...ytomorrow,"saidJackBroadbent,executiveofficerofthe...hehealthoftheirneighborsandfellowcommunitymemberst...
(Date:11/25/2009)...crease blood pressure? This simple question has b... New Stress-related gene Modulates High Blood Pres...essure? This simple question has been the focus o...ch has for the first time established a link betwe... response to stress in mice as well as humans. The...
(Date:11/25/2009)...plagued by neurological symptoms, study finds , ...Neurological side effects are among the potential ...r cancer who were treated with cisplatin-based che...ncluded 1,409 Norwegian men treated for unilateral...part in a follow-up survey conducted from 1998 to ...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...ern Medical College at Dallas report that contact ...xygen transmissible materials are expected to redu...han contact lenses which are available now. Based ...ar.// The results of the Southeastern study ar...
...he hair loss associated with drug treatment for ca...apy-induced alopecia (CIA), is a frequent side eff...g for patients at a vulnerable time in their lives...s with a skull cap to cool the scalp, minimising b...
...ion that is to blame for most panic attacks and ot...breakthrough could lead to the development of drug...ated that more than one in twelve people suffer fr...hobia. They found that 92% of the affected family ...
...rst clues to the high failure rate of cloning and ...ore of the nucleus.The discovery, announced at the...e Advancement of Science in Washington, shows that...ogether.// "Our genes are not uniformly distr...
...lder people avert a form of arthritis that can cha...lking an impossible one.Those who regularly walked...bilities to perform activities of daily living. ...elying on others for help// in these ordinary acti...
...screening technique for persons suffering from typ...rch Fund says investigations of skin lesions may a...rom a group of cancers, particularly those of the ...yposis colorectal cancer syndrome - it may be poss...
Other Medicine News:Health News:New contact lens materials 2Health News:Breakthrough in cancer therapy 2Health News:The anxiety gene, 2Health News:DNA and clones 2Health News:Arthritis risk reduced by exercise 2
(Date:11/25/2009)...25/PRNewswire-FirstCall/--HeskaCorporation(HSKA);(...specialtyproductstotheveterinaryindustry,announced...hesupplyofbloodgasproductsandaffiliatedconsumables...wscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, ...efieldofadvancedpoint-of-carediagnostics,"commente...
(Date:11/25/2009)...Newswire/--BioTrendsResearchGroup,Inc.releasedWave...rstinamulti-phasesyndicatedmarketresearchprojecttr...omproductlaunchthroughthefirstsixmonthsofavailabil...tionfrom75uniqueDermatologistsandqualitativeinform...Stelara,obstaclestouse,typicalpatienttypes,product...
(Date:11/25/2009)...ov.25/PRNewswire/--RegadoBiosciences,aprivatelyhel...erswithactivecontrolagents,announcedthatDavidMazzo...fray21stAnnualHealthCareConferenceattheNewYorkPala...ivenat1:10pm(EST)onTuesday,December1andwillinclude...eaddevelopmentprogram,theanticoagulantsystem,REG1....
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 1Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 2Esperion Therapeutics Initiates Phase I Clinical Study for ETC 1002 14833 1Esperion Therapeutics Initiates Phase I Clinical Study for ETC 1002 14833 2ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 1ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 2ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 3ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 4ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 5ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 6ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 7ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 8ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 9ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 10ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 11
...AM, England, October 7 ,Sosei Group Corporation ("... plc ("Vectura"; LSE: VEC), announce results of tw... and tolerability of NVA237 presented at the,annua...S) in Berlin,Germany. The new data show that NVA23...cting muscarinic antagonist (LAMA), provides susta...
...pens the door to the understanding of and possible... and cancer, BILLERICA, Mass., Oct. 6 Seahorse B... ever analytical instrument for the,kinetic measur...plasmic,glycolysis in cells in a 96 well microplat...lar bioenergetics have been relatively unchanged s...
Other Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3
STELLARA™
...m Thermo Labsystems was designed specifically to c... Advanced features such as the new fast dial syst...es help to define this as a new leader in single c...ate offers a custom fit for different hand sizes. ...
Corning Lambda Single Channel Pipettor, 0.1-2.5 ul
...s improved ergonomics for today's exacting laborat...finger rest and the large display windows enhance ...als also feature soft-touch tip ejection with powe... blow-out for 0.2 - 50ul micro volume pipetting. F...
Medicine Products: